Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: Mol Imaging. 2013 Jan-Feb;12(1):17–27.

Figure 1.

Figure 1

Flow cytometric analysis of epidermal growth factor receptor (EGFR) expression. The A431 epidermoid carcinoma, HCT116 colorectal cancer, T47D breast cancer, and MDA-MB435 breast cancer cell lines were evaluated for EGFR expression. Panitumumab was used as the primary antibody, and FITC-conjugated goat antihuman IgG was used as the secondary antibody. Data are shown as cell number on the ordinate access and EGFR intensity on the abscissa.